NewAmsterdam Pharma Company N.V. (NAMS) vs Neogen Corporation (NEOG)
A side-by-side comparison of NewAmsterdam Pharma Company N.V. and Neogen Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NAMS
NewAmsterdam Pharma Company N.V.
$22.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NEOG
Neogen Corporation
$11.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NAMS vs NEOG
growth of $100 · dividends reinvested · last 6yNAMS +114.9% (+13.6%/yr)NEOG -68.3% (-17.4%/yr)NAMS compounded faster over this window
Log scale — wide-divergence pair
NAMS NEOG
NAMS vs NEOG: by the numbers
- •NEOG is the larger company ($2.61B vs $2.60B market cap).
- •Both run net losses; NEOG's is the smaller (-0.91% vs -3644.21% net margin).
Metrics side by side
Valuation
| Metric | NAMS | NEOG |
|---|---|---|
| Forward P/E | N/A | 38.58 |
| P/S ratio | 365.60 | 3.00 |
| P/B ratio | 4.12 | 1.25 |
| EV / EBITDA | N/A | 32.08 |
Profitability
| Metric | NAMS | NEOG |
|---|---|---|
| Gross margin | 92.15% | 46.93% |
| Operating margin | -1002.90% | -2.49% |
| Net margin | -3644.21% | -0.91% |
| ROE | -41.10% | -0.38% |
| ROIC | -38.70% | -0.68% |
Growth (annualized)
| Metric | NAMS | NEOG |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.19% |
| Total return CAGR (5Y) | 18.30% | -21.13% |
Frequently asked
- How have NAMS and NEOG total returns compared?
- Over the past 5 years, NAMS delivered 18.30% and NEOG delivered -21.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.